The CTA was submitted Oct. 16; BioNxt anticipates review could take about three months, depending on regulators and requests ...

Krap brings over two decades of consumer-focused mergers and acquisitions advice, including food and beverage, home and ...

Goldman Sachs Bank Europe made the purchases on Nasdaq Stockholm. The program covers up to SEK 15 billion and runs until ...

The purchase averaged $169.1468 per share. IHG intends to cancel the shares; 147,035,298 were in issue, excluding 5,431,782 ...

Giredestrant data showed improved efficacy over endocrine therapy without compromising tolerability or quality of life; Roche ...

Oculis expects results around year-end 2026. The study tests eye discomfort against placebo in variant carriers and assesses ...

LONDON, UK / ACCESS Newswire / October 19, 2026 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the clinical-stage biopharmaceutical group announces that it has entered into a Feasibility Study Agreement ...

A three-month campaign is planned for October through December, with videos and editorial content on The Market Link's ...

UK Biobank's data covers 500,000 volunteers; new profiles will be returned over time and shared with approved researchers under established access procedures.

The Nova Developer Skills Package costs $390. On Oct. 26, FFR will hold its first Investor Day and listing ceremony at New ...

Acquisition closing conditions remain; Meridian's non-binding term sheet proposes up to $1 billion, with 10,000 homes planned ...

The three-year contract also includes PULS launchers, related rocket-artillery platforms and logistics support under a government-to-government agreement.